Publication | Closed Access
Biomacromolecule/lipid Hybrid Nanoparticles for Controlled Delivery of Sorafenib in Targeting Hepatocellular Carcinoma Therapy
32
Citations
40
References
2017
Year
HA/SF-cLNS demonstrated the potential to enhance antitumor efficacy of SF.
| Year | Citations | |
|---|---|---|
Page 1
Page 1